Skip to main content
FinSpry Logo
FinSpry
LYEL logo
LYEL
(NASDAQ)
Lyell Immunopharma, Inc.
$21.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lyell Immunopharma (LYEL) Stock Price & Financial Analysis

Lyell Immunopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.78 - $21.70
52-Week High$45.00
52-Week Low$7.65
Open$20.34
Volume88.86K
Average Volume (3M)88.86K
Market Cap387.46M
Shares Outstanding18.27M
Price to Sales (P/S)9272.12
Price to Book (P/B)1.16
EV/EBITDA-1.59
Revenue (TTM)41.00K
Net Income (TTM)-325.66M
Free Cash Flow (TTM)-165.53M
EPS (TTM)$-17.83
Profit Margin-794292.68%
Operating Margin-495080.49%
Return on Equity (ROE)-98.95%
Debt to Equity0.13
50-Day MA$22.97
200-Day MA$18.51
52-Week Change114.85%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lyell Immunopharma

What is the current stock price for LYEL?

As of the latest trading session, LYEL stock trades at $21.21. The 52-week range is $7.65–$45.00, with a day range of $19.78–$21.70.

What is the P/E ratio for LYEL?

The P/E ratio (Price-to-Earnings) for LYEL is shown in the Key Statistics section. This valuation metric helps compare Lyell Immunopharma, Inc. to industry peers.

Does LYEL pay dividends?

Lyell Immunopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LYEL?

Based on 1 analyst, the consensus for LYEL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LYEL?

Lyell Immunopharma's market capitalization is $387.5M, classifying it as a small-cap company. Lyell Immunopharma operates in the Healthcare sector within the Biotechnology industry.